/
CYCN
$3.91-$0.01 (-0.26%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$18.4M
5M shares
52-week range
$1.03 – $8.48
39% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-56.69
Cyclerion Therapeutics, Inc. Common Stock
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.
www.cyclerion.com- Employees
- 1
- IPO / List date
- Mar 18, 2019
- HQ
- CAMBRIDGE, MA
Held by traders on TradeandTell
No one on the platform currently holds CYCN.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2024-12-31 | 10,611 | $34.2K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2023-05-16 | 1-for-20reverse |
Recent trades on TradeandTell
No one on the platform has traded CYCN yet.
